May 2006
Volume 47, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2006
Outcomes in Silicone Rod Frontalis Suspension Surgery for Blepharoptosis
Author Affiliations & Notes
  • G.J. Lelli, Jr.
    Ophthalmology, University of Michigan, Ann Arbor, MI
  • T.N. Garvin
    Ophthalmology, University of Michigan, Ann Arbor, MI
  • C.C. Nelson
    Ophthalmology, University of Michigan, Ann Arbor, MI
  • D.C. Musch
    Ophthalmology, University of Michigan, Ann Arbor, MI
  • B.R. Frueh
    Ophthalmology, University of Michigan, Ann Arbor, MI
  • Footnotes
    Commercial Relationships  G.J. Lelli, None; T.N. Garvin, None; C.C. Nelson, None; D.C. Musch, None; B.R. Frueh, None.
  • Footnotes
    Support  Research to Prevent Blindness, Inc.
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 3972. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      G.J. Lelli, Jr., T.N. Garvin, C.C. Nelson, D.C. Musch, B.R. Frueh; Outcomes in Silicone Rod Frontalis Suspension Surgery for Blepharoptosis . Invest. Ophthalmol. Vis. Sci. 2006;47(13):3972.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To evaluate the efficacy and safety of silicone rod frontalis suspension for blepharoptosis.

Methods: : Records of consecutive patients treated with silicone rod frontalis suspension for blepharoptosis from January 1985 through January 2005 were reviewed. The records of 90 eyelids of 59 patients were culled for diagnosis, previous surgical history, patient and physician subjective impression of surgical result, pre– and post–operative margin–reflex–distance (MRD), lagophthalmos, corneal staining (modified Oxford scale) and frequency of adjustment or replacement of the sling.

Results: : Diagnoses included congenital ptosis (29 eyelids), ocular myasthenia gravis (13), chronic progressive external ophthalmoplegia (13), oculopharyngeal dystrophy (11), cranial nerve III palsy (9), benign essential blepharospasm with apraxia (7), traumatic ptosis (6) and neurofibromatosis I (2). Thirty (33%) of the patients had previous ptosis surgery prior to a silicone rod suspension procedure. Surgery resulted in a significant increase in MRD (+2.5 mm; p<0.0001). Subjective patient assessment of the surgical result was deemed ‘good’ in 39 (43%) eyelids, ‘acceptable’ in 30 (33%) and ‘poor’ in 21 (23%). Global physician impression of the surgical result was ‘good’ in 42 (47%) eyelids, ‘acceptable’ in 24 (27%) and ‘poor’ in 24 (27%). The patients’ assessment of their outcome related well to the physicians’ assessment (Kappa=0.62, 95% CI: 0.48–0.76; p<0.0001). Lagophthalmos increased significantly post–operatively (+0.56 mm, p<0.0001), but there was no significant change in corneal staining grade after surgery (p=0.20). Thirty–eight (42%) eyelids required adjustment or replacement of the silicone sling, most often for adjustment of lid height.

Conclusions: : Silicone rod frontalis suspension surgery is safe and effectively increases the MRD in blepharoptosis patients with minimal or no levator function. Patient and physician satisfaction correlate well. As expected, we note a relatively high proportion of patients who required adjustment or replacement of the slings. Silicone rod suspension surgery is chosen in these challenging ptosis cases for the ease with which these adjustments can be made.

Keywords: eyelid • clinical (human) or epidemiologic studies: outcomes/complications 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×